[1]袁源.血清糖链抗原125和人附睾分泌蛋白4联合检测在卵巢癌诊断中的价值[J].新乡医学院学报,2012,29(11):850-852.
点击复制

血清糖链抗原125和人附睾分泌蛋白4联合检测在卵巢癌诊断中的价值/HTML
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
29
期数:
2012年11期
页码:
850-852
栏目:
临床报告
出版日期:
2012-11-20

文章信息/Info

Title:
Diagnostic value of combined determination of serum carbohydrate antigen 125 and human epididymis secretory protein 4 in patients with ovarian cancer
作者:
袁源
盐城市第一人民医院妇产科;
关键词:
卵巢癌 糖链抗原125 血清人附睾分泌蛋白4

相似文献/References:

[1]图妮沙古丽·阿卜拉江,艾星子·艾里,丁岩,等.卵巢癌早期诊断相关因子研究进展[J].新乡医学院学报,,():000.
[2]韩碧波,魏海东,郑 磊,等.经阴道彩色多普勒超声联合血清糖链抗原125和人附睾蛋白4水平检测对卵巢癌的诊断价值[J].新乡医学院学报,2019,36(10):971.[doi:10.7683/xxyxyxb.2019.10.016]
 HAN Bi-bo,WEI Hai-dong,ZHENG Lei,et al.Diagnostic value of transvaginal color Doppler sonography combined with serum carbohydrate antigen 125 and human epididymis protein 4 in ovarian cancer[J].Journal of Xinxiang Medical University,2019,36(11):971.[doi:10.7683/xxyxyxb.2019.10.016]
[3]路 娜,王炳淑,古吉敏.卵巢癌组织中带状疱疹透明带样结构域蛋白1 mRNA表达与肿瘤增殖、侵袭及自噬相关基因表达的相关性[J].新乡医学院学报,2019,36(10):958.[doi:10.7683/xxyxyxb.2019.10.013]
 LU Na,WANG Bing-shu,GU Ji-min.Correlation between the expression of CUB and zona pellucida-like domains-containing protein 1 mRNA and the expression of genes related to proliferation,invasion and autophagy in ovarian cancer tissues[J].Journal of Xinxiang Medical University,2019,36(11):958.[doi:10.7683/xxyxyxb.2019.10.013]
[4]王黎伟,王志芬,孔丽茹,等.超声造影联合血清基质细胞衍生因子-1和磷酸化应激诱导蛋白1检测对卵巢癌的诊断价值[J].新乡医学院学报,2021,38(5):481.[doi:10.7683/xxyxyxb.2021.05.018]
 WANG Liwei,WANG Zhifen,KONG Liru,et al.Diagnostic value of contrast-enhanced ultrasound combined with serum stromal cell-derived factor-1 and stress-induced phosphoprotein 1 for ovarian cancer[J].Journal of Xinxiang Medical University,2021,38(11):481.[doi:10.7683/xxyxyxb.2021.05.018]
[5]于 鹤,刘光新.新辅助化学治疗联合肿瘤细胞减灭术治疗晚期卵巢癌疗效观察[J].新乡医学院学报,2020,37(3):258.[doi:10.7683/xxyxyxb.2020.03.014]
 YU He,LIU Guangxin.Effect of neoadjuvant chemotherapy combined with cytoreductive surgery in the treatment of advanced ovarian cancer[J].Journal of Xinxiang Medical University,2020,37(11):258.[doi:10.7683/xxyxyxb.2020.03.014]
[6]张镛镛,王 芳,雷利娜,等.血清高迁移率族蛋白A2、糖链抗原19-9联合ROMA指数对卵巢癌的诊断价值[J].新乡医学院学报,2020,37(5):471.[doi:10.7683/xxyxyxb.2020.05.17]
 ZHANG Yongyong,WANG Fang,LEI Lina,et al.Diagnostic value of serum high mobility group protein A2,carbohydrate antigen 19-9 and ROMA index in ovarian cancer[J].Journal of Xinxiang Medical University,2020,37(11):471.[doi:10.7683/xxyxyxb.2020.05.17]
[7]豆秋彦,冯 文,李春霖.脂肪因子chemerin在女性常见恶性肿瘤中的作用研究进展[J].新乡医学院学报,2020,37(12):1195.[doi:10.7683/xxyxyxb.2020.12.021]
[8]仝玉珠.腹腔镜下全面分期手术治疗早期卵巢癌疗效观察[J].新乡医学院学报,2018,35(9):804.[doi:10.7683/xxyxyxb.2018.09.013]
 TONG Yu-zhu.Clinical effect of laparoscopic radical staged surgery in the treatment of early ovarian cancer[J].Journal of Xinxiang Medical University,2018,35(11):804.[doi:10.7683/xxyxyxb.2018.09.013]
[9]何社红,薛聪玲.谷胱甘肽转移酶-π与卵巢癌多药耐药的关系[J].新乡医学院学报,2017,34(4):320.[doi:10.7683/xxyxyxb.2017.04.020]
 HE She-hong,XUE Cong-ling.Relationship between glutathione S-transferase-π and multidrug resistance of ovarian cancer[J].Journal of Xinxiang Medical University,2017,34(11):320.[doi:10.7683/xxyxyxb.2017.04.020]
[10]何社红,薛聪玲.蛋白激酶C活性与卵巢癌多药耐药性的相关性[J].新乡医学院学报,2017,34(7):660.[doi:10.7683/xxyxyxb.2017.07.029]
 HE She-hong,XUE Cong-ling.Correlation between protein kinase C activity and multidrug resistance in ovarian cancer[J].Journal of Xinxiang Medical University,2017,34(11):660.[doi:10.7683/xxyxyxb.2017.07.029]

更新日期/Last Update: 2013-12-30